The BC Cancer Agency Compassionate Access Program: outcome analysis of patients with esophagogastric cancer

BACKGROUND: The BC Cancer Agency Gastro-intestinal Tumor Group supports one standard of care (soc) chemotherapy regimen for metastatic esophagogastric adenocarcinoma—specifically, weekly cisplatin and 5-fluorouracil (5fu) infusion. All other regimens require Compassionate Access Program (cap) approv...

Descripción completa

Detalles Bibliográficos
Autores principales: Wilson, K.S., Barnett, J.B., Shah, A., Khoo, K.E.
Formato: Texto
Lenguaje:English
Publicado: Multimed Inc. 2009
Materias:
Medical Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2768501/
https://www.ncbi.nlm.nih.gov/pubmed/19862357

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2768501/
https://www.ncbi.nlm.nih.gov/pubmed/19862357

Ejemplares similares